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IN VITRO SENSITIVITY SCREENING
SYSTEM FOR HUMAN CANCERS TO
DRUGS AND HYPERTHERMIA (420C).
J. A. DICKsoN and M. SUZANGAR. Cancer
Research Unit, Department of Clinical
Biochemistry, University of Newcastle upon
Tyne.
Approximately 75% of a series ofover200
human solid neoplasms were sensitive to
either hyperthermia (42°C) or cytotoxic
drug(s), or a combination of these, as defined
by a 30% or greater inhibition of respiration
and/or anaerobic glycolysis brought about by
the agent in fresh and/or cultured tumour.
The inhibition was paralleled by decreased
radioactive precursor incorporation into
DNA, RNA and protein by the tumour slices.
In a solid Yoshida rat tumour there was close
correlation between the biochemical response
in vitro to heat and drugs and the in vivo
response of the tumour. Sensitivity in this
system is taken to indicate a drug and/or
heat responsive cell population within the
tumour. The extent to which such a result
predicts patient response will depend upon
the existence or emergence of resistant cells
inthetumour in vivo, and on the sensitivity of
metastatic cells.
THE NATURE OF THE RESISTANCE
TO METHYLENE DIMETHANE SUL-
PHONATE IN THE YOSHIDA
SARCOMA. B. W. Fox and M. Fox.
Paterson Laboratories, Christie Hospital,
Manchester.
In order to define the biochemical change
responsible for the induction of resistance
towards a potent antitumour agent methyl-
ene dimethane sulphonate, tumours in vivo
have been transferred to in vitro conditions in
which they grow continuously as single cell
suspension cultures. Both resistant and
sensitive cells are maintained in vitro anc
cross-resistant studies indicate that the two,
cell lines show a similar wide difference in"
sensitivity to ultraviolet radiation and sul-
phur mustard, but no difference to x-rays
and methyl methane sulphonate. This pat-
tern of sensitivity implies a deficiency on the
part of the sensitive cells of a step in the
repair of damage produced in the DNA by
u.v. or MDMS but not by x-rays and MMS.
This has been shown to be the case and the
Yoshida sensitive line thus resembles the
human repair deficiency disease ofxeroderma
pigmentosum.
EVIDENCE FOR THE ACTIVE INTER-
MEDIATE IN CYCLOPHOSPHAMIDE
METABOLISM. P. J. Cox (introduced by
T. A. CONNORS). Chester Beatty Research
Institute, London.
Two ethyl derivatives of an intermediate
ofcyclophosphamide metabolism, 4-hydroxy-
cyclophosphamide, have now been isolated
and identified, by T.L.C. and mass spectro-
metry, in extracts of microsomal incubations
with[32P]-cyclophosphamide. Bytheuseofa
cell culture bioassay technique, these deriva-
tives have been shown to be highly toxic to
Walker ascites cells. The toxicities of
various previously identified metabolites
were assessed in an in vitro bioassay system.
The results were consistent with the view that
the formation of4-hydroxycyclophosphamide
is the important step in the activation of
cyclophosphamide, as this metabolite can
break down spontaneously to the active
alkylating agent, phosphoramide mustard
[N,N-bis(2-chloroethyl) phosphorodiamidic
acid], and acrolein. 4-hydroxycyclophos-
phamide has been tentatively inferred as the
hydrolysis product of both ethyl derivatives
isolated, but attempts to extract more than
minute quantities ofthe free metabolite from
in vitro microsomal incubations have been
unsuccessful.
ENZYME ACTIVATED ALKYLATING
AGENTS. C. R. BALL, J. A. DOUBLE and
J. GOODBAN. Department of Cancer Re-
search, University of Leeds.
Recently Ross and co-workers (Bukhari,
Everett and Ross, Biochem. Pharmac., 1971,
21, 963) published the syntheses of 3 con-
jugates of p-hydroxyaniline mustard which
they suggested might be selective for tumours
with high levels of ,B-glucuronidase, phos-
phatase and sulphatase. The 0-glucuronide,
0-phosphate and 0-sulphate respectively
were expected to be deconjugated in vivo by
the appropriate enzymes. High enzyme
activity in a particular tumour could lead to
selectivity of action due to the greater release
of the rapidly reacting p-hydroxyaniline
mustard in the tumour than elsewhere.
We have determined the ability of the
appropriate enzymes to utilize these drugs
(kindly supplied by Professor Ross) as sub-82 B.A.C.R. 14TH ANNUAL GENERAL MEETING
strates. The 0-phosphate was readily de-
conjugated by all acid and alkaline phos-
phatases tested but no evidence was obtained
for cleavage of the 0-sulphate by limpet or
rat liver microsomal or lysosomal sulphatases.
The 0-glucuronide was a good substrate for
mammalian liver lysosomal glucuronidases.
These results appear to eliminate the 0-
sulphate as a suitable drug for enzyme
activation but substantiate the possible
usefulness of the 0-phosphate and 0-
glucuronide.
Friday 6 April
IN VITRO EFFECTS OF ICRF 159. K.
HELLMANN and R. C. HALLOWES. Depart-
ments of Cancer Chemotherapy and Patho-
logy, Imperial Cancer Research Fund,
London.
The effects of ICRF 159 were studied on
transformed hamster cells in culture. 5 cm
dishes were each plated with 104 cells and
cultured at 37°C for up to 72 hours in Eagle's
medium containing a range of concentrations
ofICRF 159. The cells were either harvested
at the completion of the culture period or
were transferred to drug-free medium.
Cell numbers increased to 2*5 x 104
during the first 24 hours invarious concentra-
tions of ICRF 159 up to 20 ,tg/ml, but the
rate of increase diminished with increasing
drug concentrations during the next 48 hours.
The rate of increase returned towards control
values when cells were transferred to drug-
free medium, provided the change occurred
before 72 hours and only in drug concentra-
tions of less than 10 tug/ml.
Specific morphological changes occurred
in cells exposed to the drug which may enable
the site ofaction ofthe drug to be determined.
EFFECTS OF THE ANTICOAGULANT,
DEGRADED CARRAGEENAN, ON
EXPERIMENTAL TUMOUR GROWTH.
B. JOLLES, R. G. HARRISON and E. A.
MOORE. Cancer and Radiobiology Research
Laboratories, General Hospital, North-
ampton.
As the survival ofan experimental tumour
graft depends largely on the formation by the
host ofa newtumour stroma toreplace thatof
the graft which is absorbed within 48-72
hours of implant, the study of substances
with " anticoagulant " and fibrinolytic pro-
perties is of importance (O'Meara, Irish J.
med. Sci., 1958, 474; Jolles, Lancet, 1963,
iii, 1234).
In previous work, the effects of inter-
ference with some fundamental events in
connective tissue by heparin (Jolles and
Greening, Acta Un. int. Cancer., 1960, 16,
682) and of laminarin, a mucopolysaccharide
derived from the seaweed Laminaria cloustoni
(Jolles, Remington and Andrews, Br. J.
Canicer, 1963, 17, 109) have been shown to
reduce the rate of growth of Sarcoma S.180 in
mice.
In the present series, in which the design
of the experiments was along the same lines
as those followed in the heparin andlaminarin
studies, a degraded Carrageenan derived
from red seaweeds injected subcutaneously
(0 05 ml in a 1-0, 1-5 or 2% concentration)
3 times weekly for 2 weeks, or twice weekly
for 4 weeks at a site adjacent to the implanted
tumour or intraperitoneally (0-1 ml/animal)
reduces the rate of tumour growth.
PROLACTIN AND BREAST CANCER.
P. G. SALUJA, J. M. HAMILTON and M.
GRONOW. Department of Experimental
Pathology and Cancer Research, University
of Leeds.
Although prolactin is of supreme impor-
tance in the aetiology and genesis of rodent
mammary tumours (Muhlbock and Boot,
Cancer Res., 1959, 19, 402; Pearson et al.,
Trans. Ass. Am. Physns, 1969, 82, 225), it is
not known whether it is implicated in mam-
mary carcinogenesis in other species. In
view of the many similarities that exist
between human and canine breast cancer
(Misdorp, 1964, Thesis, Utrecht; Schneider,
Cancer, N. Y., 1970, 26, 419), an investigation
was carried out ofthe prolactin concentration
in the adenohypophysis of dogs afflicted with
breast tumours.
Baseline values were established for
normal dogs in which pituitary prolactin
concentration was found to vary according to
reproductive state (e.g. low in dioestrus,
high in lactation). In bitches with mam-
mary carcinoma, prolactin levels were signifi-
cantly higher than in normal subjects of com-
parable endocrine state. This finding indi-
cates that prolactin imbalance may be
involved in canine mammary neoplasia.